Press release
Pertussis Market Growth Projections 2024-2034: DelveInsight Analysis | ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, Serum Institute, Bilthoven
DelveInsight's "Pertussis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Pertussis, historical and forecasted epidemiology as well as the Pertussis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pertussis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pertussis Market Forecast [https://www.delveinsight.com/sample-request/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Some of the key facts of the Pertussis Market Report:
*
The Pertussis market size is anticipated to grow with a significant CAGR during the study period (2020-2034)
*
To assess vaccination coverage for each dose of the DTP vaccine in the 7MM, data from the WHO/UNICEF Joint Reporting Form on Immunization (JRF), country-specific organizations, and research studies were utilized.
*
In 2022, pertussis vaccination coverage in the United States reached around 19 million individuals. The highest coverage was observed in the 18 and older age group, with approximately 5 million vaccinations administered.
*
According to DelveInsight's estimates, around 34 million people were vaccinated against Pertussis in the 7MM in 2022, and this number is expected to grow throughout the forecast period (2024-2034).
*
Key Pertussis Companies: Sanofi Pasteur, GlaxoSmithKline, ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, and others
*
Key Pertussis Therapies: ADACEL, BOOSTRIX, BPZE1, BK1310/MT-2355, and others
*
The Pertussis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Pertussis pipeline products will significantly revolutionize the Pertussis market dynamics.
Pertussis Overview
Pertussis, also known as whooping cough, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. It is characterized by severe coughing fits, often with a "whooping" sound when the person breathes in after coughing. Pertussis can affect people of all ages, but it is particularly severe in infants and young children who have not been fully vaccinated.
Get a Free sample for the Pertussis Market Report
https://www.delveinsight.com/report-store/pertussis-market [https://www.delveinsight.com/report-store/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Pertussis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Pertussis Epidemiology Segmentation:
The Pertussis market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
*
Total Prevalence of Pertussis
*
Prevalent Cases of Pertussis by severity
*
Gender-specific Prevalence of Pertussis
*
Diagnosed Cases of Episodic and Chronic Pertussis
Download the report to understand which factors are driving Pertussis epidemiology trends @ Pertussis Epidemiology Forecast [https://www.delveinsight.com/sample-request/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Pertussis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Pertussis market or expected to get launched during the study period. The analysis covers Pertussis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Pertussis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Pertussis Therapies and Key Companies
*
ADACEL: Sanofi Pasteur
*
BOOSTRIX: GlaxoSmithKline
*
BPZE1: ILiAD Biotechnologies
*
BK1310/MT-2355: Mitsubishi Tanabe Pharma Corporation
Discover more about therapies set to grab major Pertussis market share @ Pertussis Treatment Market [https://www.delveinsight.com/sample-request/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Pertussis Market Drivers
*
Increase in the recommendation of vaccination programs in pregnant women
*
Increasing Awareness Programs
*
Increasing population of pertussis
Pertussis Market Barriers
*
Acellular vaccines less effective in the current market
*
Lack of patient awareness
*
Barriers to developing a new whole-cell version of pertussis vaccine
*
Different vaccination policies amongst various countries
Scope of the Pertussis Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Pertussis Companies: Sanofi Pasteur, GlaxoSmithKline, ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, and others
*
Key Pertussis Therapies: ADACEL, BOOSTRIX, BPZE1, BK1310/MT-2355, and others
*
Pertussis Therapeutic Assessment: Pertussis current marketed and Pertussis emerging therapies
*
Pertussis Market Dynamics: Pertussis market drivers and Pertussis market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Pertussis Unmet Needs, KOL's views, Analyst's views, Pertussis Market Access and Reimbursement
To know more about Pertussis companies working in the treatment market, visit @ Pertussis Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/pertussis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]
Table of Contents
1. Pertussis Market Report Introduction
2. Executive Summary for Pertussis
3. SWOT analysis of Pertussis
4. Pertussis Patient Share (%) Overview at a Glance
5. Pertussis Market Overview at a Glance
6. Pertussis Disease Background and Overview
7. Pertussis Epidemiology and Patient Population
8. Country-Specific Patient Population of Pertussis
9. Pertussis Current Treatment and Medical Practices
10. Pertussis Unmet Needs
11. Pertussis Emerging Therapies
12. Pertussis Market Outlook
13. Country-Wise Pertussis Market Analysis (2020-2034)
14. Pertussis Market Access and Reimbursement of Therapies
15. Pertussis Market Drivers
16. Pertussis Market Barriers
17. Pertussis Appendix
18. Pertussis Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=pertussis-market-growth-projections-20242034-delveinsight-analysis-iliad-biotechnologies-mitsubishi-tanabe-pharma-corporation-serum-institute-bilthoven]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pertussis Market Growth Projections 2024-2034: DelveInsight Analysis | ILiAD Biotechnologies, Mitsubishi Tanabe Pharma Corporation, Serum Institute, Bilthoven here
News-ID: 4128623 • Views: …
More Releases from ABNewswire
Windy City Chimney Heroes Announces Expanded Service Areas Across the Greater Ch …
Windy City Chimney Heroes, a long-standing chimney company established in 1997, has expanded its service areas across the Greater Chicago region. The company now serves Chicago, Evanston, Oak Park, Naperville, Schaumburg, Cicero, Skokie, Berwyn, and Arlington Heights. Owner Wesley Cook says the expansion will help meet rising demand for reliable chimney repair and inspection services.
Windy City Chimney Heroes, a trusted chimney repair and maintenance provider founded in 1997, has announced…
Injury 2 Wellness Centers Promotes Wellness Care Through Ongoing Chiropractic Su …
As the year draws to a close and many individuals begin setting health goals for the new year, Injury 2 Wellness Centers is encouraging Georgia residents to prioritize wellness care through consistent chiropractic treatment. Far beyond addressing back or neck pain, chiropractic care can serve as a foundation for long-term physical health, improved function, and overall quality of life.
Decatur, GA - December 10, 2025 - As the year draws to…
Avalon Tree Services Reminds Atlanta Homeowners to Prioritize Winter Tree Care f …
As temperatures drop and trees enter their dormant season, Avalon Tree Services is reminding homeowners across Greater Atlanta that winter is one of the most important times to invest in proper tree care. Cold weather, ice accumulation, and seasonal storms can all take a toll on tree health and stability-making preventative maintenance essential for safety and long-term growth.
Atlanta, GA - December 10, 2025 - As temperatures drop and trees enter…
TrueProfit Shares 2026 Guidance for Shopify Startups to Focus on Profit First No …
As Shopify heads into 2026 with millions of active stores worldwide and continued growth in global ecommerce, TrueProfit - a Net Profit Analytics platform for Shopify merchants - is urging new founders to treat profitability as a starting requirement, not an afterthought.
With a low barrier to entry and a mature app ecosystem, Shopify remains one of the easiest ways to launch an online business. But TrueProfit's latest briefing on early-stage…
More Releases for Pertussis
Diphtheria, Pertussis, and Tetanus Vaccine Market
According to a new report published by Allied Market Research, titled, "Diphtheria, Pertussis, and Tetanus Vaccine Market by Product Type [DTaP (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel), Td (Decavac and Tenivac), and Tdap (Boostrix and Adacel)], Vaccine Type (Whole-Cell Vaccine and Acellular Vaccine), Age Group (Adult and Pediatric), and End User (Hospitals, Clinics, and Vaccination Centers) - Global Opportunity and Forecast, 2019-2026 ".
The Global market size of Diphtheria, Pertussis,…
Growth in Adoption of Pertussis Vaccination and Government Insurance are Project …
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free…
Global Pertussis Vaccine Consumption 2016 Market Research Report
The Global Pertussis Vaccine Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Pertussis Vaccine market.
First, the report provides a basic overview of the Pertussis Vaccine industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.
Secondly, the report states the global Pertussis Vaccine market size (volume and value),…
Pertussis Vaccine Market: Estimated to Flourish by 2016 - 2024
The Pertussis Vaccine Market report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size.
Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S,…
Pertussis Vaccine Industry 2024 Market Research Report
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free…
Pertussis Vaccine Industry 2024 Market Research Report
Pertussis vaccine is used for whooping cough. This vaccine is available only in combination with other vaccines. Pertussis vaccination is recommended for all children, babies, teens, and pregnant women. Diphtheria, tetanus, and pertussis (DTaP) vaccines are given to children younger than seven years old, while tetanus, diphtheria, and pertussis (Tdap) vaccines are given to older children and adults. Childhood vaccination is one of the safest and cost-effective ways for pertussis-free…
